KPV

Evidence: ★★☆☆☆ · Status: Not Approved

In plain English

A tiny anti-inflammatory peptide, mostly explored for gut inflammation and skin. Early data only.

How it works

C-terminal tripeptide of α-MSH; anti-inflammatory via melanocortin/NF-κB suppression in gut and skin — studied for IBD and wound healing.

Molecular target & official sources

Alpha-MSH/POMC (NCBI Gene) · KPV (PubChem)

Bottom line

Promising gut/skin anti-inflammatory; limited human evidence.

Helps with: Recover Faster · Gut Health · Skin & Hair

Stacks with

Shares a pathway — often paired with: Omega-3 (EPA/DHA), Statins (Atorvastatin/Rosuvastatin), SGLT2 Inhibitors (Empagliflozin / Canagliflozin), Saffron (Crocus sativus).

Availability & where to buy

Not widely approved. Not approved for general sale in most markets (Singapore included). Grey-market only — dose, purity and legality uncertain.

How it works: the NF-κB / Inflammation pathway →